Argent Biopharma Ltd (ASX: RGT) Share Price and News

Price

$0.094

Movement

0.004 (+4.44%)

As at 6 Jun - Closed (20 mins delayed)

52 Week Range

$0.09 - $0.57

 
1 Year Return

-70.63%

Argent Biopharma Ltd Chart and Price Data

2025
2025
2025
2025
$0.00
$0.20
$0.40
$0.00
$0.20
$0.40
$0.00
$0.20
$0.40
$0.00
$0.20
$0.40

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $6.79 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 72.18 million
Earnings per share -0.407
Dividend per share N/A
Year To Date Return -47.06%
Earnings Yield N/A
Franking -
Earnings Yield

N/A

Franking

-

Dividend per share

N/A

Year To Date Return

-47.06%

Shares Outstanding

72.18 million

Earnings per share

-0.407

Share Price

$0.094

Day Change

0.004 (+4.44%)

52 Week Range

$0.09 - $0.57

Yesterday's Close

$0.09

Today's Open

$0.09

Days Range

$0.09 - $0.097

Volume

36,097

Avg. Volume (1 month)

59,748

Turnover

$3,390

As at 6 Jun - Closed

  • Argent Biopharma Ltd (ASX: RGT)
    Latest News

    a woman
    Share Gainers

    Why cannabis company MGC Pharmaceuticals surged 13% higher today

    The MGC Pharmaceuticals Ltd (ASX:MXC) share price surged 13% higher today after the cannabis company provided a positive update...

    Read more »

    a woman
    Share Gainers

    Why these ASX cannabis shares surged higher today

    The Botanix Pharmaceuticals Ltd (ASX:BOT) share price and the MGC Pharmaceuticals Ltd (ASX:MXC) share price have surged higher on Wednesday.…

    Read more »

    a woman
    Share Gainers

    Why these ASX cannabis shares are rocketing higher today

    The MGC Pharmaceuticals Ltd (ASX:MXC) share price and the THC Global Group Ltd (ASX:THC) share price are two of four…

    Read more »

    a woman
    Share Gainers

    Why cannabis company MGC Pharmaceuticals rocketed 38% higher today

    The MGC Pharmaceuticals Ltd (ASX:MXC) share price rocketed 38% higher on Wednesday. Here's why this cannabis company smoked the market...

    Read more »

    a woman
    Share Gainers

    MGC Pharma share price lifts on botanical update

    A botanical update from cannabis producer MGC Pharmaceuticals Ltd (ASX:MXC) has seen its share price respond favourably today as the company posted…

    Read more »

    a woman
    Share Gainers

    The AusCann share price is flying high and up 36% in a month

    The AusCann Group Holdings Ltd (ASX:AC8) share price is now up 36% in a month. Here's why it is on…

    Read more »

    a woman
    Share Gainers

    ASX cannabis shares have started the year on a high

    The Auscann Group Holdings Ltd (ASX:AC8) share price and the Creso Pharma Ltd (ASX:CPH) share price have started the year…

    Read more »

    a woman
    Share Gainers

    These small cap ASX shares are ending the week on a high

    The Amaysim Australia Ltd (ASX:AYS) share price is one of three at the small end of the market ending the…

    Read more »

    a woman
    Share Gainers

    Why these cannabis shares smoked the market on Tuesday

    Cannabis shares BOD Australia Ltd (ASX:BDA), Hydroponics Company Ltd (ASX:THC), and MGC Pharmaceuticals Ltd (ASX:MXC) smoked the market on Tuesday...

    Read more »

    a woman
    Share Market News

    These 3 ASX small cap shares have stormed higher on Thursday

    The Biotron Limited (ASX:BIT) share price is one of three storming higher at the small end of the market on…

    Read more »

    a woman
    Share Gainers

    Why MGC Pharmaceuticals Ltd (ASX:MXC) shares have rocketed 27% higher today

    Cannabis company MGC Pharmaceuticals Ltd (ASX:MXC) has outperformed the market today with a massive 27.5% push higher...

    Read more »

    a woman
    Share Market News

    Why these 3 ASX shares are in trading halts today

    ResApp Health Ltd (ASX:RAP) shares are one of three missing out on the market meltdown due to being in trading…

    Read more »

    RGT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    2nd May 2025 2025-05-02T17:08:23 Notification of cessation of securities - RGTYesNo5:08pm515k
    30th Apr 2025 2025-04-30T09:42:18 Quarterly Activities/Appendix 4C Cash Flow ReportYesNo9:42am11585k
    24th Apr 2025 2025-04-24T11:40:38 s708A Cleansing NoticeYesNo11:40am1322k
    24th Apr 2025 2025-04-24T11:35:43 Application for quotation of securities - RGTYesNo11:35am818k
    24th Apr 2025 2025-04-24T11:34:28 Cancel - Application for quotation of securities - RGTYesNo11:34am818k
    23rd Apr 2025 2025-04-23T18:51:19 s708A Cleansing NoticeYesNo6:51pm1324k
    23rd Apr 2025 2025-04-23T18:46:09 Application for quotation of securities - RGTYesNo6:46pm818k
    23rd Apr 2025 2025-04-23T18:44:19 Application for quotation of securities - RGTYesNo6:44pm819k
    23rd Apr 2025 2025-04-23T18:41:29 Application for quotation of securities - RGTYesNo6:41pm818k
    23rd Apr 2025 2025-04-23T18:41:29 Application for quotation of securities - RGTYesNo6:41pm818k

    About Argent Biopharma Ltd

    MGC Pharmaceuticals Ltd. engages in the production of medical marijuana. Its Endocannabinoid system covers all cells and nerves; it is the messenger of information flowing between immune system and the central nervous system. The company was founded by Nativ Segev on October 21, 2005 and is headquartered in Perth, Australia.

    RGT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    05 Jun 2025 $0.09 $-0.01 -10.20% 9,156 $0.09 $0.10 $0.09
    04 Jun 2025 $0.10 $0.01 11.11% 41,000 $0.09 $0.10 $0.09
    03 Jun 2025 $0.09 $-0.01 -10.53% 23,644 $0.10 $0.10 $0.09
    02 Jun 2025 $0.10 $0.00 0.00% 27,134 $0.10 $0.10 $0.09
    30 May 2025 $0.10 $0.00 0.00% 27,769 $0.09 $0.10 $0.09
    29 May 2025 $0.10 $0.00 0.00% 144,824 $0.10 $0.10 $0.09
    28 May 2025 $0.10 $0.00 0.00% 32,046 $0.10 $0.10 $0.10
    27 May 2025 $0.09 $-0.01 -10.10% 237,812 $0.10 $0.10 $0.09
    26 May 2025 $0.10 $-0.02 -17.39% 81,352 $0.10 $0.10 $0.09
    23 May 2025 $0.12 $0.01 9.09% 7,579 $0.12 $0.12 $0.11
    22 May 2025 $0.11 $0.00 0.00% 26,940 $0.11 $0.11 $0.11
    21 May 2025 $0.11 $-0.01 -8.70% 218,154 $0.11 $0.12 $0.11
    20 May 2025 $0.12 $0.00 0.00% 37,277 $0.12 $0.12 $0.12
    19 May 2025 $0.12 $0.00 0.00% 9,978 $0.12 $0.12 $0.12
    16 May 2025 $0.12 $0.00 0.00% 167,250 $0.12 $0.12 $0.12
    15 May 2025 $0.12 $0.00 0.00% 62,157 $0.13 $0.13 $0.12
    14 May 2025 $0.12 $-0.01 -7.69% 16,031 $0.12 $0.13 $0.12
    13 May 2025 $0.13 $-0.02 -13.33% 50,366 $0.15 $0.16 $0.12
    12 May 2025 $0.15 $0.04 34.78% 30,458 $0.12 $0.15 $0.12
    09 May 2025 $0.12 $0.00 0.00% 18,510 $0.11 $0.12 $0.11
    08 May 2025 $0.12 $0.00 0.00% 6,295 $0.12 $0.12 $0.12
    07 May 2025 $0.12 $0.00 0.00% 26,359 $0.12 $0.12 $0.12

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    15 Oct 2024 Roby Zomer Buy 4,000,000 $1,640,000
    As advised by the company.
    10 Sep 2024 Roby Zomer Buy 1,258,500 $503,400
    Off-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Daniel Robinson Non-Executive Director Dec 2023
    Mr Robinson has been appointed as a Non-Executive Director of the Company effective immediately. Mr Robinson has over 20 years of experience in a broad range of corporate roles across stockbroking, corporate advisory, investor relations and governance. He is an experienced Company Secretary and Director of both private and listed companies. Additionally, Mr Robinson is a Member of the Australian Institute of Company Directors.
    Mr Roby Reuven Zomer Chief Executive OfficerManaging Director Feb 2016
    Mr Zomer is an executive with experience in the biopharmaceutical and biotech industries. As the CEO of the company, Roby has demonstrated has driven strategic growth, managed financial operations, and ensured compliance with industry-specific standards. He also served as the Chairman of the Board for Graft Polymer, overseeing the implementation of advanced polymer solutions in the Biotech, Automotive and Recycling sectors. Roby's entrepreneurial background includes founding and leading Green City Urban Recycling, a pioneering Israeli company focused on biofuel production. His innovative work in this field contributed to national energy independence initiatives and led to the company's acquisition by Rafael Advanced Defense Systems. With an industrial engineering and management foundation, Roby Zomer brings a blend of technical and strategic skills to his professional endeavors.
    Mr Gary Hermon Non-Executive Director Mar 2025
    Mr Hermon is a Company Director with over 30 years of experience in telecommunications, electrical systems, and infrastructure rollout. Throughout his career, he has managed projects for clients, including Hewlett-Packard, the Victorian Government, BP, and ExxonMobil. Previously, Mr Hermon founded Hercomm Cables & Security, where he managed nationwide rollouts for Hewlett-Packard and the Victorian Government. He also has experience overseeing electrical systems and communications for BP and ExxonMobil in Indonesia, India, and Papua New Guinea.
    Mr Rowan Harland Company Secretary Mar 2023
    -
    Rowan Harland Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Oak Capital Partners Llc 8,370,718 17.29%
    Group Capital Llc 3,913,812 8.09%
    David Safren 3,405,016 7.03%
    Citicorp Nominees Pty Limited 2,301,084 4.75%
    Shlomie Bierman 2,230,874 4.61%
    Computershare Clearing Pty Ltd <Ccnl Di A/C> 2,099,936 4.34%
    Isamar Margareten 1,956,906 4.04%
    Mr Shachar Shimony 1,933,000 3.99%
    Yaakov Safren 1,643,802 3.40%
    Jacob Goldstein 1,623,072 3.35%
    Yoram Drucker 1,604,664 3.32%
    Yosef Safren 1,565,526 3.23%
    Shalom Safren 1,448,112 2.99%
    Bioheka Limited 1,258,500 2.60%
    Mrs Yifat Steuer 1,117,194 2.31%
    Eliron Yaron 750,000 1.55%
    A1 Invest Llc 625,000 1.29%
    Mr Itay David Nissim 600,000 1.24%
    Mr Amir Polak 592,626 1.22%
    Joseph Schwartz 547,934 1.14%

    Profile

    since

    Note